Between 18 June and 20 September 1986, 28 cases of Plasmodium vivax malaria were
documented in Carlsbad, California, a coastal town north of San Diego. Malaria occurred in …

Background Plasmodium vivax poses a significant challenge to malaria elimination due to
its ability to cause relapsed infections from reactivation of dormant liver parasites called …

Clinical trials documented alarming post-treatment Plasmodium vivax recurrence rates
caused by recrudescence of surviving asexual blood stages, relapse from hypnozoites, or …

Successful establishment of a Plasmodium vivax sporozoite challenge model in humans is
described. Eighteen healthy adult, malaria-naïve volunteers were randomly allocated to …

Abstract Malaria, both Plasmodium falciparum (Welch) and Plasmodium vivax (Grassi &
Feletti), has reemerged as a significant public health disease issue in Peru, especially in …

The global prevalence of malaria has decreased over the past fifteen years, but similar gains
have not been realized against Plasmodium vivax because this species is less responsive to …

Background Chloroquine (CQ) over three days plus primaquine (PQ) for seven days is the
treatment of choice of infections by Plasmodium vivax in Bolivia, where 95% of the cases of …

A safe and reproducible Plasmodium vivax infectious challenge method is required to
evaluate the efficacy of malaria vaccine candidates. Seventeen healthy Duffy (+) and five …

Background The groundwork for malaria elimination does not currently consider the
potential of Plasmodium zoonotic cycles that involve non-human primates (NHPs) in sylvatic …

Abstract All South American countries except Chile and Uruguay currently experience
transmission of human malaria, which is one of the commonest maladies treated at health …